Mirvetuximab soravtansine (solution)

(Synonyms: IMGN853 (solution))
3 Cited Publications
Customer Review

Based on 3 publication(s) in Google Scholar

Mirvetuximab soravtansine (IMGN853) solution is an anti-folate receptor α (FRα) antibody drug-conjugate (ADC) consisting of the cytotoxic maytansinoid, DM4, covalently linked to the humanized monoclonal antibody M9346A, and the drug-linker conjugate for ADC is sulfo-SPDB-DM4 (HY-101141). Mirvetuximab soravtansine selectively binds to folate receptor 1 (FOLR1). Mirvetuximab soravtansine has an anti-proliferative effect via growth arrest and augmented DNA damage.

For research use only. We do not sell to patients.

  • Purity: 97.25%
  • CAS No.: 1453084-37-1
  • Molecular Weight:150000 (average)
  • Storage:

    -80°C, protect from light

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Customer Validation & Images
Cell Proliferation/Viability AssayApoptosis AnalysisBio/Physico-chemical Assay
  • Cell Proliferation/Viability Assay
  • Cell Proliferation/Viability Assay
  • Cell Proliferation/Viability Assay
  • Apoptosis Analysis
  • Bio/Physico-chemical Assay
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00